PharmGen Science, Inc. Logo

PharmGen Science, Inc.

A pharmaceutical company that researches, develops, produces, and sells medicaments.

004720 | KO

Overview

Corporate Details

ISIN(s):
KR7004720009
LEI:
Country:
South Korea
Address:
경기 화성시 향남면 상신리 향남제약공단 902-5, 화성시

Description

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-08-19 00:00
[기재정정]반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-12 00:00
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 15.9 KB
2025-06-12 00:00
전환청구권ㆍ신주인수권ㆍ교환청구권행사
Korean 14.0 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.8 MB
2025-04-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-04-14 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.0 KB
2025-04-14 00:00
주식등의대량보유상황보고서(일반)
Korean 110.0 KB
2025-04-11 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 14.4 KB
2025-04-10 00:00
주식등의대량보유상황보고서(약식)
Korean 677.5 KB
2025-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-03 00:00
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 34.9 KB

Automate Your Workflow. Get a real-time feed of all PharmGen Science, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmGen Science, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmGen Science, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.